
Velia is an emerging biotech company focused on harnessing the therapeutic potential of a newly identified class of human proteins. Unlike most biotech firms that target known drug targets, Velia aims to uncover novel biology by discovering and characterizing disease-relevant proteins across the human proteome. Their unique approach integrates deep expertise in protein discovery, functional genomics, and artificial intelligence to develop first-in-class therapeutics. With a strong leadership team and backing from notable investors, Velia is positioned to make significant advancements in the biotech field.

Velia is an emerging biotech company focused on harnessing the therapeutic potential of a newly identified class of human proteins. Unlike most biotech firms that target known drug targets, Velia aims to uncover novel biology by discovering and characterizing disease-relevant proteins across the human proteome. Their unique approach integrates deep expertise in protein discovery, functional genomics, and artificial intelligence to develop first-in-class therapeutics. With a strong leadership team and backing from notable investors, Velia is positioned to make significant advancements in the biotech field.